[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 6 - The Spring Supplement of Shefaye Khatam 1 - ::
Shefaye Khatam 2018, 6 - The Spring Supplement of Shefaye Khatam 1 -: 185-185 Back to browse issues page
P154: Role of Exosomes as Novel Biomarkers in Diagnosis and Prognosis of Glioblastoma
Mohsen Estiri *
Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran , mohsen.est1377@gmail.com
Abstract:   (986 Views)
Glioblastoma multiform(GBM) is the most prevalent primary brain tumor. Exosomes are extracellular vehicles for exchanging information between various cell types including cancer and normal cells. Exosomes are indicative of pathophysiological conditions of brain tumors that could be used in diagnosis and prognosis of GBM. In tumors, exosomes could carry various molecules like several miRNAs and proteins from host cells to recipient cells leading to development of tumor. Exosomes can be isolated from blood serum in different manners. One way is using antibodies against exosomal markers. What makes the exosomes "ideal" biomarkers for clinical diagnosis and prognosis is that exosomal miRNAs and proteins are protected from RNases and proteases respectively, thus can be stably detected in circulating serum. For instance, it has been shown that the upregulated miRNA-326 and miRNA-130a, and downregulated miRNA-323 and miRNA-329 could be associated with long overall survival in GBM patients. Also it is found that circulating miRNA-128 and miRNA-342-3p were positively correlated with histopathological grades of GBM. Moreover, it is indicated that miRNA-24 could be an oncogene and be used as diagnostic biomarker. On the other hand, Serum exosomes from patients with brain tumors possess EGFR, EGFRvIII, TGF-beta, and Tetraspanins which are potentially useful in diagnosis of GBM. There are few studies in term of using exosomes as tumor biomarkers but we claim that the most important advantage of exosomes is their potential to be used as biomarkers for clinical diagnosis and prognosis. Further studies are needed to prove this concept and make it operative in clinics.
Keywords: Glioblastoma Multiform, Exosomes, Micrornas, Diagnosis, Prognosis
Full-Text [PDF 245 kb]   (198 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Estiri M. P154: Role of Exosomes as Novel Biomarkers in Diagnosis and Prognosis of Glioblastoma. Shefaye Khatam. 2018; 6 (S1) :185-185
URL: http://shefayekhatam.ir/article-1-1658-en.html


Volume 6 - The Spring Supplement of Shefaye Khatam 1 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.04 seconds with 32 queries by YEKTAWEB 4212